首页> British journal of clinical pharmacology> Cost-utility and cost-effectiveness analysis of a clinical medication review focused on personal goals in older persons with polypharmacy compared to usual care: Economic evaluation of the DREAMeR study.

Cost-utility and cost-effectiveness analysis of a clinical medication review focused on personal goals in older persons with polypharmacy compared to usual care: Economic evaluation of the DREAMeR study.

导出原文传递

翻译打印收藏纠错

第一作者： Sanne,Verdoorn

第一单位： Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.;SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands.

作者： Sanne,Verdoorn ^[1] ; Jeroen,van de Pol ^[2] ; Anke M,Hövels ^[2] ; Henk-Frans,Kwint ^[3] ; Jeanet W,Blom ^[4] ; Jacobijn,Gussekloo ^[5] ; Marcel L,Bouvy ^[1]

作者单位： Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.;SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands. ^[1] Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands. ^[2] SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands. ^[3] Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands. ^[4] Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.;Department of Internal Medicine, section Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands. ^[5]

关键词 clinical medication review cost-effectiveness older persons polypharmacy primary care randomised controlled trial